北大医药
(000788)
| 流通市值：36.53亿 | | | 总市值：36.53亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 957,309,406.16 | 502,359,685.42 | 2,060,014,642.65 | 1,534,330,245.12 |
| 营业收入 | 957,309,406.16 | 502,359,685.42 | 2,060,014,642.65 | 1,534,330,245.12 |
| 二、营业总成本 | 837,453,429.08 | 449,551,963.27 | 1,856,768,030.42 | 1,371,419,826.74 |
| 营业成本 | 710,055,592.22 | 382,158,273.99 | 1,507,540,914.04 | 1,108,500,741.03 |
| 税金及附加 | 5,161,517.29 | 2,491,717.2 | 10,904,583.93 | 8,032,811.75 |
| 销售费用 | 66,029,184.5 | 37,062,146.95 | 202,183,825.02 | 168,872,186.41 |
| 管理费用 | 45,767,951.66 | 23,406,614.27 | 109,751,555.25 | 73,033,945.27 |
| 研发费用 | 11,833,550.53 | 5,179,004.74 | 27,041,662.02 | 13,294,511.08 |
| 财务费用 | -1,394,367.12 | -745,793.88 | -654,509.84 | -314,368.8 |
| 其中:利息费用 | 1,320,858.96 | 1,855,384.78 | 4,168,555.1 | 2,421,511.97 |
| 其中:利息收入 | 2,791,137.86 | 3,831,511.71 | 5,025,465.72 | 2,880,150.25 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | -235,738.82 | - |
| 资产处置收益 | -45,752.14 | - | 185,840.72 | 185,840.72 |
| 资产减值损失(新) | -51,160.27 | -5,916.05 | -46,250,443.11 | -4,282,872.37 |
| 信用减值损失(新) | -1,387,658.8 | -933,768.69 | 11,529,003.17 | 2,203,524.12 |
| 其他收益 | 2,013,249.74 | 1,113,371.75 | 3,521,782.22 | 2,914,977.22 |
| 四、营业利润 | 120,384,655.61 | 52,981,409.16 | 171,997,056.41 | 163,931,888.07 |
| 加:营业外收入 | 1,695,301.34 | 1,654,364.32 | 1,160,586.09 | 176,145.37 |
| 减:营业外支出 | 56,069.96 | 54,741.02 | 804,590.68 | 796,552.43 |
| 五、利润总额 | 122,023,886.99 | 54,581,032.46 | 172,353,051.82 | 163,311,481.01 |
| 减:所得税费用 | 21,729,977.83 | 8,940,482.25 | 34,360,447.09 | 32,997,749.93 |
| 六、净利润 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 | 130,313,731.08 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 | 130,313,731.08 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 | 130,364,988.72 |
| 少数股东损益 | - | - | - | -51,257.64 |
| 扣除非经常损益后的净利润 | 98,163,827.28 | 43,984,087.53 | 127,259,270.95 | 129,545,990.23 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.17 | 0.08 | 0.23 | 0.22 |
| (二)稀释每股收益 | 0.17 | 0.08 | 0.23 | 0.22 |
| 九、综合收益总额 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 | 130,313,731.08 |
| 归属于母公司股东的综合收益总额 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 | 130,364,988.72 |
| 归属于少数股东的综合收益总额 | - | - | - | -51,257.64 |
| 公告日期 | 2025-08-22 | 2025-04-25 | 2025-04-25 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |